Colorectal cancer cells with either a KRAS or BRAF mutation exhibited high expression levels of the glucose transporter-1 (GLUT1) gene and were able to survive in low glucose environments; whereas, the wild type cells exhibited low levels of GLUT1 and were not viable in low glucose conditions [41]. Here, BRAF is linked to colorectal cancer.